Ibotta, Inc.
NYSE:IBTASoftware - Application
-$0.19 today
- Market cap
- $1.14B
- Beta
- -0.58
- P/E (TTM)
- -96.1
- EPS (TTM)
- -$0.30
Volume 0.31M
Average 0.22M
IBTA Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Ibotta, Inc.NYSE: IBTA
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses dips below year-ago levels
Q1 FY2026 other income / expenses of $1.48M fell 55.0% year over year, behind the +164.0% change in trailing-twelve-month other income / expenses. Sequentially, it fell 21.6% from the prior quarter.
Context
- Other income / expenses amounted to 2.4% of revenue in FY2025, up 1.5 pp from a year earlier.
- Other income / expenses increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -55.0% toward the trailing-twelve-month pace of +164.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- 8.19M USD
- Year-over-year change
- +338.9%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.19M | +338.9% |
| FY2024 | 2024-12-31 | (3.43M) | +71.3% |
| FY2023 | 2023-12-31 | (11.95M) | +16.4% |
| FY2022 | 2022-12-31 | (14.29M) | — |
Other Income / Expenses vs competitors
How IBTA compares with its peers on the latest reported figures
- Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +164.0% is the 2nd highest of 10, against a peer median of -45.7%.
- Other income / expenses amounts to 2.6% of revenue for IBTA, versus a peer median of 3.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CN¥1.05B CNY | +29.3% | +22.8% | 8.3% | |
| LTM Mar 2026 | $18.71M USD | +174.0% | — | 14.7% | |
| LTM Mar 2026 | $9.95M USD | -45.7% | -9.8% | 2.8% | |
| LTM Mar 2026 | $8.88M USD | +164.0% | — | 2.6% | |
| LTM Mar 2026 | $1.46M USD | +8.4% | +59.3% | 1.5% | |
| LTM Mar 2026 | $566K USD | -92.3% | — | 0.2% | |
| LTM Mar 2026 | -$2.42M USD | -157.1% | — | 1.0% | |
| LTM Mar 2026 | -$16.32M USD | -153.9% | — | 15.1% | |
| LTM Mar 2026 | -$23.82M USD | +26.0% | — | 3.9% | |
| LTM Mar 2026 | -$65.38M USD | -93.5% | — | 11.6% | |
| Peer median (excluding IBTA) | — | -45.7% | +22.8% | 3.9% | |
Competitors are the stored peer set for IBTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 210.7M | 320.04M | 367.25M | 342.39M |
| Cost of Revenue | 49.22M | 47.65M | 50.12M | 74.97M |
| Gross Profit | 161.48M | 272.38M | 317.13M | 267.42M |
| Gross Margin | 76.6% | 85.1% | 86.4% | 78.1% |
| Research & Development | 42.56M | 50M | 63.27M | 61.08M |
| Selling, General & Admin | 159.23M | 166.39M | 221.95M | 207.18M |
| Operating Expenses | 201.79M | 216.39M | 289.21M | 265.77M |
| Depreciation & Amortization | 6.32M | 6.66M | 8.08M | 8.32M |
| EBITDA | (42.97M) | 57.6M | 32.58M | 18.17M |
| EBITDA Margin | -20.4% | 18.0% | 8.9% | 5.3% |
| Operating Income | (40.31M) | 56M | 27.93M | 1.66M |
| Operating Margin | -19.1% | 17.5% | 7.6% | 0.5% |
| Interest Income | 0 | 0 | 9.41M | 10.78M |
| Interest Expense | 5.31M | 6.88M | 0 | 0 |
| Other Income / Expenses | (14.29M) | (11.95M) | (3.43M) | 8.19M |
| Income Before Tax | (54.6M) | 44.05M | 24.5M | 9.85M |
| Pre-Tax Margin | -25.9% | 13.8% | 6.7% | 2.9% |
| Income Tax Expense | 262K | 5.93M | (44.25M) | 6.27M |
| Net Income | (54.86M) | 38.12M | 68.74M | 3.58M |
| Net Margin | -26.0% | 11.9% | 18.7% | 1.0% |
| EPS (Basic) | (1.81) | 1.26 | 2.85 | 0.13 |
| EPS (Diluted) | (1.81) | 1.26 | 2.56 | 0.12 |
| Weighted Avg Shares | 30.24M | 30.24M | 24.12M | 28.37M |
| Weighted Avg Shares (Diluted) | 30.24M | 30.24M | 26.86M | 30.1M |
Ibotta, Inc.
NYSE:IBTA
Intrinsic Alpha fair value
Locked
Current Price
$55.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.